Skip to content
★ Sign in to follow
TP

Thomas Pålsson

Stayble Therapeutics AB
Total declarations
13
Company
1
▲ Purchases (11 ops.)
€24k
▼ Sales (0 ops.)
—

Latest filing published 12 Jun 2024 for Stayble Therapeutics AB, €912.

Filing timeline

BuySale
Thomas Pålsson

Insider track record

Disclosed buys
11
Disclosed sells
0
Signal history

Closed purchases

Market purchases
11

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Thomas Pålsson: trading record in brief

All filings by Thomas Pålsson on record concern Stayble Therapeutics AB. In total, 13 filings cover trades dated from 26 February 2020 to 12 June 2024.

The open-market record is one-sided, with 11 purchases worth €24k and not one sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2024 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €1,513. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 12 June 2024 with an open-market purchase (€912) in Stayble Therapeutics AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas Pålsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    10,240 SEK32FI-SE
    32,000 shares@ SEK 0.3210.4% of flowAktieISIN SE0013513652FI:csv-bec7d04ba1f19f06af92
    Canonical exit: 10 Sept 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    13,900 SEK20FI-SE
    50,000 shares@ SEK 0.27814.1% of flowAktieISIN SE0013513652FI:csv-0ee06b8ea4407fa9a9e8
    Canonical exit: 7 Mar 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    9,600 SEK20FI-SE
    5,000 shares@ SEK 1.929.5% of flowAktieISIN SE0013513652FI:csv-08ed8dc4d5245cfdbae6
    Canonical exit: 12 Oct 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    109,973 SEK0FI-SE
    5,000 shares@ SEK 21.9946AktieISIN SE0013513652FI:csv-3e40ab153d8f6d316d35
    Canonical exit: 12 Oct 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    38,400 SEK23FI-SE
    30,000 shares@ SEK 1.2838.0% of flowAktieISIN SE0013513652FI:csv-fa02a9d396ebf70c3e30
    Canonical exit: 22 Aug 2023 (T+90)
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    0FI-SE
    8,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-6b35c146bf06c19ac8c2
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    0FI-SE
    3,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-a3a5252eb93aa7cdbdb2
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    20,328 SEK0FI-SE
    11,420 shares@ SEK 1.7820.4% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-d40602e3759420b06e67
    Canonical exit: 11 Jul 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    7,618 SEK0FI-SE
    4,280 shares@ SEK 1.787.6% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-8eabebea7d339f938d53
    Canonical exit: 11 Jul 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    8,360 SEK0FI-SE
    1,000 shares@ SEK 8.36AktieISIN SE0013513652FI:csv-bf2afc8feebe79a88d2d
    Canonical exit: 8 Dec 2021 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesStayble Therapeutics AB
    29,760 SEK0FI-SE
    4,000 shares@ SEK 7.44AktieISIN SE0013513652FI:csv-9b308ba43b582a98d2d1
    Canonical exit: 7 Sept 2021 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesStayble Therapeutics AB
    24,600 SEK0FI-SE
    2,000 shares@ SEK 12.30AktieISIN SE0013513652FI:csv-9492944e16ef4736e44b
    Canonical exit: 26 May 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesStayble Therapeutics AB
    0FI-SE
    2,000 shares0TeckningsoptionISIN SE0013748381FI:csv-8eb1019b4934e8638837
    Canonical exit: 26 May 2020 (T+90)

13 of 13 declarations